Fochon Pharmaceuticals, Ltd.   Report issue

For profit Phase 1
Founded: San Leandro CA United States (2009)

Organization Overview

First Clinical Trial
2019
NCT03951116
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Fochon Pharmaceuticals, Ltd.

Active Ingredients

Drugs in Phase 1 Trials (4)

fcn-011 (1 trial)

fcn-098 (1 trial)

fcn-338 (1 trial)

fcn-437c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 4
  • # of Trial APIs: 4